This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis

Authoring team

The prognosis depends on the type of tumour and the aggressiveness of the lesion:

  • benign mediastinal tumours, if excised, usually have a good prognosis
  • thymomas:
    • benign - excellent prognosis but there is a 2% recurrence rare if excision is incomplete
    • malignant type I - excellent prognosis if resection is complete
    • malignant type II - approximate 20% 5-year survival after treatment.
  • neuroblastomas - there may be as high as a 60% 5-year survival rate after treatment.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.